SPECT脑血流灌注显像和受体显像对抑郁症的研究

原凌; 刘建中; 武志芳

原凌 , 刘建中 , 武志芳

文章导航 > 国际放射医学核医学杂志 > 2007, 31 > 5: (277-280)

引用本文:

Citation:

SPECT脑血流灌注显像和受体显像对抑郁症的研究

030001 太原, 山西医科大学第一医院核医学科
中图分类号: R814.42;R749.4

The study of SPECT cerebral blood flow and neuroreceptor imaging in depressive disorders

Department of Nuclear Medicine, The First Hospital of Shanxi Medical University, Taiyuan 030001, China
CLC number: R814.42;R749.4

摘要: 抑郁症的影像学检查有结构性脑成像和功能性脑成像,CT和MRI检查脑结构的异常既不显著又不具有特异性,而PET和SPECT提供了在活体内对抑郁症进行局部脑血流灌注和中枢神经递质与受体结构和功能的研究,为进一步探讨抑郁症的病因、发病机制以及临床治疗提供客观依据.
- 抑郁症 /
- 体层摄影术,发射型计算机,单光子 /
- 血液灌注 /
- 受体,5-羟色胺 /
- 受体,多巴胺
Abstract: The imaging methods of depressive disorders include structural imaging and functional imaging, the abnormal of cerebral structure in CT and MRI is neither significant nor specific, while the use of PET and SPECT provides depression study in-vivo about regional cerebral blood flow and central neurotransmitter and receptor's structure and function, which further have advanced research on aetiology, pathogenesis and therapy of depressive disorders.
- Depressive disorders /
- Tomography,emission-computer,single-photon /
- Hemopeffusion /
- Receptor,5-hydroxytryptamine /
- Receptor,dopamime
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Krausz Y, Bonne O, Marciano R, et al. Brain SPECT imaging of neuropsychiatric disorders. Eur J Radiol, 1996, 21(3):183-187.
[2]	Bonne O, Louzoun Y, Aharon I, et al. Cerebral blood flow in depressed patients:a methodological comparison of statistical parametric mapping and region of interest analyses. Psyehiatry Res, 2003, 122(1):49-57.
[3]	Mayberg HS, Liotti M, Brannan SK, et al. Reciprocal limbic-corticol function and negative mood:converging PET findings in depression and normal sadness. Am J Psychiatry, 1999, 156(5):675-682.
[4]	Drevets WC. Neuroimaging studies of mood disorder. Biol Psychiatry, 2000.48(8):813-829.
[5]	Smith D J, Cavanagh JT. Tile use of single photon emission computed tomography in depressive disorders. Nucl Med Commun, 2005, 26(3):197-203.
[6]	Videbeeh P. PET measurements of brain glucose metabolism and hlood flow in major depressive disorder:a critical review. Acta Psychiat Scand, 2000, 101(1):11-20.
[7]	Vangu MD, Esser JD, Boyd IH, et al. Effects of electroconvulsive therapy on regional cerebral blood flow measured by 99mtechnetium HMPAO SPECT. Prog Neuropsy chopharmacol Biol Psychiatry, 2003, 27(1):15-19.
[8]	Tutus A, Simsek A, Sofuoglu S,et al. Changes in regional cerebral blood flow demonstrated by single photon emission computed tomography in depressive disorders:comparison of unipolar vs. bipolar subtypes. Psychiatry. Res, 1998, 83(3):169-177.
[9]	Davies J, Lloyd KR, Jones IK, et al. Changes in regional cerebral blood flow with venlafaxine in the treatment of major depression. Am J Psychiatry, 2003, 160(2):374-376.
[10]	Perieo CA. Skaf CR, Yamada A, et al. Relationship between regional cerebral blood flow and separate symptom clusters of major depression:a single photon emission computed tomography study using statistical parametric mapping. Neurosci Lett, 2005, 384(3):265-270.
[11]	Benabarre A, Vieta E, Martin F, et al. Clinical value of ^99mTc-HMPAO SPECT in depressed bipolar Ⅰ patients. Psychiatry Res, 2004, 132(3):285-289.
[12]	Kruger S, Alda M, Young UF, et al. Risk and resilience markers in bipolar disorder:brain responses to emotional challenge in bipolar patients and their healthy siblings. Am J Psychiatry, 2006, 163(2):257-264.
[13]	Fountoulakis KN, Iacovides A, Gerasimou G, et al. The relationship of regional cerebral hlood flow with subtypes of major depression. Prog Neuropsychopharmacol Biol Psychiatry, 2004, 28(3):537-546.
[14]	Gonul AS, Kula M, Bilgin AG, et al. The regional cerebral blood flow changes in major depressive disorder with and without psychotic features. Prog Neuro-psychopharmacol Biol Psychiatry, 2004, 28(6):1015-1021.
[15]	Bonne O, Krausz Y, Gorfine M, et al. Cerebral hypopeffusion in medication resistant, depressed patients assessed by Tc-99m HMPAO SPECT. J Affect Disord. 1996, 41(3):163-171.
[16]	Kimura M, Shimoda K, Mizumura S, et al. Regional cerebral blood flow in vascular depression assessed by ¹²³I-IMP SPECT. J Nippon Med Sch, 2003, 70(4):321-326.
[17]	Drevets WC, Bogers W, Raichle ME, Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of legional glucose metabolism. Eur Neuro psychopharmacol, 2002, 12(6):527-544.
[18]	Malison RT, Price Lld, Berman R, el al. Reduced brain serotonin transporter availability in major depression as measured by[¹²³I]-2[beta]-carbomethoxy-3[beta]-(4-iodophenyl) tropane and single photon emission computed tomography. Biol Psychiatry, 1995, 44(11):1090-1098.
[19]	Willeit M. Praschak-Rieder N, Neumeister A, et al.[¹²³I]-[beta]-CIT SPECT imaging shows rednced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biol Psychiatry, 2000, 47(6):482-489.
[20]	van Dyck CH, Malinson RT, Staley JK, et al. Central serotonin transporter availability measured with[¹²³I] [beta]-CIT SPECT in relation to serotonin transporter genotype. Am J Psychiatry, 2004, 161(3):523-531.
[21]	Cowen PJ. Serotouin receptor subtypes:implications for psychopharmacology. Br J Psychiatry Suppl, 1991, (12):7-14.
[22]	Klimke A, Larisch R, Janz A, et al. Dopamine D2 receptor binding before and after treatment of major depression measured by[¹²³I] IBZM SPECT. PsychiatlT Res, 1999, 90(2):91-101.

[1]	赵晋华 , 林祥通 . 抑郁症的放射性核素脑血流灌注和脑受体显像研究进展. 国际放射医学核医学杂志, 1998, 22(2): 49-51.
[2]	于璟 , 唐一源 . SPECT在抑郁症研究中的应用. 国际放射医学核医学杂志, 2007, 31(1): 13-16.
[3]	宁艳丽 , 晋建华 . 癫痫脑内相关受体改变及其PET研究. 国际放射医学核医学杂志, 2009, 33(2): 65-67. doi: 10.3760/cma.j.issn.1673-4114.2009.02.001
[4]	邱晶 , 王慧 , 王蕾 , 周治强 , 徐雅洁 , 顾卫国 . 首次发作抑郁症患者静息态fMRI低频振幅的初步研究. 国际放射医学核医学杂志, 2020, 44(8): 499-506. doi: 10.3760/cma.j.cn121381-201904004-00061
[5]	冯苏洋 , 邢炯 , 舒敏 , 刘加成 . 抑郁症相关执行功能障碍的磁共振成像研究进展. 国际放射医学核医学杂志, 2021, 45(12): 795-799. doi: 10.3760/cma.j.cn121381-202012010-00117
[6]	袁建伟 , 冯彦林 , 贺小红 , 余丰文 , 刘德军 , 温广华 , 黄克敏 . ^20lTl定量门控心肌灌注体层显像与^99mTc-红细胞门控心血池显像测定左心室射血分数的对比研究. 国际放射医学核医学杂志, 2008, 32(2): 86-88.
[7]	陈贵兵 , 欧阳忠 , 韩成坤 , 黄劲雄 , 何小江 , 王凡 , 贾兵 , 吴华 . ⁹⁹Tc^m-3PRGD2整合素受体显像在乳腺癌定性诊断中的价值及与钼靶检查的对比研究. 国际放射医学核医学杂志, 2017, 41(1): 1-7. doi: 10.3760/cma.j.issn.1673-4114.2017.01.001
[8]	赵娟 , 刘兴党 . 实验性近视眼视网膜多巴胺神经系统研究进展. 国际放射医学核医学杂志, 2007, 31(2): 73-76.
[9]	胡鹏程 , 顾宇参 , 刘文官 , 修雁 , 朱玮珉 , 陈曙光 , 石洪成 . 腺苷负荷脑灌注显像安全性研究. 国际放射医学核医学杂志, 2009, 33(2): 83-85. doi: 10.3760/cma.j.issn.1673-4114.2009.02.006
[10]	薛荣梅 , 宋丽萍 . 门控心肌灌注SPECT在冠心病方面的应用进展. 国际放射医学核医学杂志, 2006, 30(6): 353-355.